Zobrazeno 1 - 10
of 32
pro vyhledávání: '"G. K. Ellis"'
Autor:
Jennifer M. Specht, Vijayakrishna K. Gadi, Julie Gralow, Hannah M. Linden, G. K. Ellis, L Rubinstein, E Cho, Qian Wu
Publikováno v:
Cancer Research. 77:P5-14
BACKGROUND: The addition of taxanes to anthracycline-based adjuvant chemotherapy has improved disease free survival (DFS) in women with high-risk early-stage breast cancer. Many studies have sought to optimize the dose intensity and density of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd730709a8f9cea818e8d3c02f17ee0
https://doi.org/10.1158/1538-7445.sabcs16-p5-14-10
https://doi.org/10.1158/1538-7445.sabcs16-p5-14-10
Autor:
Vijayakrishna K. Gadi, Hannah M. Linden, ET Rodler, Jennifer M. Specht, Julie Gralow, Savannah C. Partridge, R. Doot, Erin K. Schubert, David A. Mankoff, G. K. Ellis, JK Eun, Brenda F. Kurland, Lisa K. Dunnwald
Publikováno v:
Cancer Research. 71:P2-09
Background Kinetic analysis of FDG PET and DCE-MRI can identify patterns of breast tumor metabolism and perfusion that predict pathologic response, relapse, and survival in patients (pts) receiving neoadjuvant chemotherapy (NC). We are enrolling pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90766a9142cab34408bc09c40ebd50cf
https://doi.org/10.1158/0008-5472.sabcs11-p2-09-09
https://doi.org/10.1158/0008-5472.sabcs11-p2-09-09
Autor:
William B. Eubank, Mary Austin-Seymour, K. L. Lindsley, G. K. Ellis, Julie Gralow, R. B. Livingston, A. Charlop, T. J. Shanley, J. Takasugi, Janet F. Eary, C. P. Funkhouser, David A. Mankoff, Hubert Vesselle
Publikováno v:
Journal of Clinical Oncology. 19:3516-3523
PURPOSE: To determine the prevalence of suspected disease in the mediastinum and internal mammary (IM) node chain by 18fluorodeoxyglucose (FDG) positron emission tomography (PET), compared with conventional staging by computed tomography (CT) in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7671e09a2ea9fde311067840103b0848
https://doi.org/10.1200/jco.2001.19.15.3516
https://doi.org/10.1200/jco.2001.19.15.3516
Autor:
Matthew A. Williams, Robert B. Livingston, G. K. Ellis, C A Long, R White, C McGuirt, Julie R. Gralow, B B Adamkiewicz
Publikováno v:
Journal of Clinical Oncology. 15:1395-1400
PURPOSE We evaluated weekly single-agent intravenous (IV) vinorelbine as salvage therapy for metastatic breast cancer. After the first five patients, all received elective growth factor support with granulocyte colony-stimulating factor (G-CSF; filgr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be415eb4b2d954c020c4d6f047c6759
https://doi.org/10.1200/jco.1997.15.4.1395
https://doi.org/10.1200/jco.1997.15.4.1395
Publikováno v:
The International Journal of Biological Markers. 11:203-206
Breast cancer patients on dose-intensive chemotherapy often have elevated tumor markers during the course of treatment. Our objective was to estimate the incidence of a “false positive” tumor marker screen and to determine whether hand-foot epith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2357ef8e54430238ae2f2d0db86db9
https://doi.org/10.1177/172460089601100404
https://doi.org/10.1177/172460089601100404
Autor:
Erin K. Schubert, Skyler K. Lindsley, David A. Mankoff, G. K. Ellis, Lisa K. Dunnwald, Robert B. Livingston, William B. Eubank, Janet F. Eary, Hubert Vesselle, Mary Austin-Seymour, Julie R. Gralow
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 22(1)
Cases of recurrence of breast cancer can pose considerable diagnostic and therapeutic challenges for the oncologic team. The prognosis and management decisions are based on knowledge of the true extent of disease. Conventional staging methods, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ced18c60fc088a302675de081e295e
https://pubmed.ncbi.nlm.nih.gov/11796893
https://pubmed.ncbi.nlm.nih.gov/11796893
Publikováno v:
Cancer. 85(11)
Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d8b971dbc6f12279c6d5fdc2ae4a33c
https://pubmed.ncbi.nlm.nih.gov/10357412
https://pubmed.ncbi.nlm.nih.gov/10357412
Autor:
William E. Barlow, R. Doot, Jennifer M. Specht, Vijayakrishna K. Gadi, Hannah M. Linden, Julie Gralow, G. K. Ellis, Lanell M. Peterson, Lisa K. Dunnwald, Erin K. Schubert, Susan Montgomery, Alena Novakova, David A. Mankoff
Publikováno v:
Cancer Research. 73:P4-01
Background: Assessing response to therapy in patients (pts) with bone-dominant (BD) metastatic breast cancer is challenging by conventional imaging such as CT and bone scintigraphy. In prior retrospective analyses, measures of FDG uptake by FDG PET w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6708954d5f049ea11c3d61a3ea2c7233
https://doi.org/10.1158/0008-5472.sabcs13-p4-01-01
https://doi.org/10.1158/0008-5472.sabcs13-p4-01-01
Autor:
David A. Mankoff, Lanell M. Peterson, Julie Gralow, Erin K. Schubert, Brenda F. Kurland, S. Xiaoyu, Robert B. Livingston, G. K. Ellis, Vijayakrishna K. Gadi, Hannah M. Linden, Jennifer M. Specht
Publikováno v:
Journal of Clinical Oncology. 29:e21077-e21077
e21077 Background: In estrogen receptor positive (ER+) tumors, a low proliferative index (Ki-67) two weeks into endocrine therapy predicts response. FDG PET non-invasively measures multiple tumor s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::733ec1b8de1987d0e1c34f4f291956b9
https://doi.org/10.1200/jco.2011.29.15_suppl.e21077
https://doi.org/10.1200/jco.2011.29.15_suppl.e21077
Autor:
David A. Mankoff, Robert B. Livingston, G. K. Ellis, Vijayakrishna K. Gadi, Brenda F. Kurland, Julie Gralow, Erin K. Schubert, Lanell M. Peterson, Hannah M. Linden, Jennifer M. Specht
Publikováno v:
Journal of Clinical Oncology. 27:11075-11075
11075 Background: Early decline in proliferative index (Ki-67) predicts response to endocrine therapy. For estrogen receptor positive (ER+) tumors, a low Ki-67 two weeks into endocrine therapy also predicts response (Dowsett JNCI 2007). FDG PET is pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::503c362084331126b3a12163e315a273
https://doi.org/10.1200/jco.2009.27.15_suppl.11075
https://doi.org/10.1200/jco.2009.27.15_suppl.11075